Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Reexamination Certificate
2011-01-25
2011-01-25
Kim, Young J (Department: 1637)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
C435S006120, C435S091200
Reexamination Certificate
active
07875441
ABSTRACT:
Oligonucleotides targeted to HPV Type 16 and/or Type 18 nucleic acid sequences which are particularly useful to aid in detecting HPV type 16 and or 18 are described. The oligonucleotides can aid in detecting HPV Type 16 and/or Type 18 in different ways such as by acting as hybridization assay probes, helper probes, and/or amplification primers.
REFERENCES:
patent: 4886741 (1989-12-01), Schwartz
patent: 4983728 (1991-01-01), Herzog et al.
patent: 5030557 (1991-07-01), Hogan et al.
patent: 5182377 (1993-01-01), Manos et al.
patent: 5185439 (1993-02-01), Arnold et al.
patent: 5283171 (1994-02-01), Manos et al.
patent: 5399491 (1995-03-01), Kacian et al.
patent: 5484699 (1996-01-01), Bouma et al.
patent: 5501947 (1996-03-01), Emery et al.
patent: 5580970 (1996-12-01), Hendricks et al.
patent: 5597910 (1997-01-01), Gudibande et al.
patent: 5654416 (1997-08-01), Cummins et al.
patent: 5679509 (1997-10-01), Wheeler et al.
patent: 5750334 (1998-05-01), Cerutti et al.
patent: 5783412 (1998-07-01), Morris et al.
patent: 6218104 (2001-04-01), Morris et al.
patent: 6583278 (2003-06-01), Carter
patent: 2004/0018539 (2004-01-01), Gordon et al.
patent: 2005/0260562 (2005-11-01), Gordon et al.
patent: 2006/0121516 (2006-06-01), Norman et al.
patent: 0 402132 (1990-12-01), None
patent: 0 477972 (1992-01-01), None
patent: 0 489442 (1992-10-01), None
patent: 0 524807 (1993-01-01), None
patent: 8806634 (1988-09-01), None
patent: WO 8902934 (1989-04-01), None
patent: WO 8902896 (1989-08-01), None
patent: 90 02821 (1990-03-01), None
patent: 91 08312 (1991-06-01), None
patent: 92 01815 (1992-02-01), None
patent: 94 26934 (1994-11-01), None
patent: 95 28942 (1995-11-01), None
Paper et al., “Use of sulfonated primers to detect and type papillomavirus in cell cultures and cervical biopsies”, Gene, 1991, pp. 155-161, vol. 103(2), Elsevier BV, Amsterdam, The Netherlands.
Jacobs et al., “Group-Specific Differentiation between High- and Low-Risk Human Papillomavirus Genotypes by General Primer-Mediated PCR and Two Cocktails of Oligonucleotide Probes”, J. Clin. Microbiol., Apr. 1995, pp. 901-905, vol. 33, No. 4, American Society for Microbiology, Washington, D.C., USA.
Auvinen et al., “Expression of the L2 and E7 Genes of the Human Papillomavirus Type 16 in Female Genital Dysplasias”, Am. J. Pathol., 1992, pp. 1217-1224, vol. 141, No. 5, American Society for Investigative Pathology, Bethesda, MD, USA.
Burns et al., “Detection of Low Copy Human Papilloma Virus DNA and mRNA in Routine Paraffin Sections of Cervix by Non-isotopic in Situ Hybridisation”, J. Clin. Pathol., 1987, pp. 858-864, vol. 40, Association of Clinical Pathologists, London, UK.
Cooper et al. “Episomal and Integrated Human Papillomavirus in Cervical Neoplasia shown by Non-isotopic in situ Hybridisation”, J. Clinl. Pathol., 1991, pp. 990-996, vol. 44, Association of Clinical Pathologists, London, UK.
Crum et al., “Topography of Early HPV 16 Transcription in High-Grade Genital Precancers”, Am. J. Pathol., 1989, pp. 1183-1188, vol. 134, No. 6, American Society for Investigative Pathology, Bethesda, MD, USA.
Belaguli et al., “Nucleotide 880 Splice Donor Site Required for Efficient Transformation and RNA Accumulation by Human Papillomavirus Type 16 E7 Gene”, J. Virol., 1992, pp. 2724-2730, vol. 66, No. 5, American Society for Microbiology, Washington, D.C., USA.
Coutlee et al., “Detection of Transcripts of Human Papillomaviruses 16 and 18 in Cancer-Derived Cell Lines and Cervical Biopsies by Enzyme Immunoassay for DNA-RNA Hybrids following Solution Hybridization”, J. Clin. Microbiol., 1991, pp. 968-974, vol. 29, No. 5, American Society for Microbiology, Washington, D.C., USA.
Herrington et al., “Detection of High Risk Human Papillomavirus in Routine Cervical Smears: Strategy for Screening”, J. Clin. Pathol., 1992, pp. 385-390, vol. 45, Association of Clinical Pathologists, London, UK.
Inagaki et al., “Nucleotide Sequences of cDNAs for Human Papillomavirus Type 18 Transcripts in HeLa Cells”, J. Virol., 1998, pp. 1640-1646, vol. 62, No. 5, American Society for Microbiology, Washington, D.C., USA.
Jeon et al., “Integration of Human Papillomaviruses Type 16 DNA into the Human Genome Leads to Increased Stability of E6 and E7 mRNAs: Implications for Cervical Carcinogenesis”, Proc. Natl. Acad. USA, Feb. 1995, pp. 1654-1658, vol. 92, U.S. National Academy of Science, Washington, D.C., USA.
Kaur et al., “Characterization of Primary Human Keratinocytes Transformed by Human Papillomavirus Type 18”, J. Virol., 1988, pp. 1917-1924, vol. 62, No. 6, American Society for Microbiology, Washington, D.C., USA.
Margall et al., “Detection of Human Papillomavirus 16 and 18 DNA in Epithelial Lesions of the Lower Genital Tract by In Situ Hybridization and Polymerase Chain Reaction: Cervical Scrapes Are Not Substitutes for Biopsies”, J. Clin. Microbiol., 1993, pp. 924-930, vol. 31, No. 4, American Society for Microbiology, Washington, D.C., USA.
McNicol et al., “Detection of Human Papillomavirus DNA in Prostate Gland Tissue by Using the Polymerase Chain Reaction Amplification Assay”, J. Clin. Microbiol., 1990, pp. 409-412, vol. 28, No. 3, American Society for Microbiology, Washington, D.C., USA.
McNicol et al., “Expression of Human Papillomavirus Type 16 E-6-E7 Open Reading Frame Varies Quantitatively in Biopsy Tissue from Different Grades of Cervical Intraepithelial Neoplasia”, J. Clin. Microbiol., May 1995, pp. 1169-1173, vol. 33, No. 5, American Society for Microbiology, Washington, D.C., USA.
Nuovo et al., “Occurrence of Multiple Types of Human Papillomavirus in Genital Tract Lesions”, Am. J. Pathol., 1991, pp. 53-58, vol. 138, No. 1, American Society for Investigative Pathology, Bethesda, MD, USA.
Ranki et al., “Use of AffiProbe HPV Test Kit for Detection of Human Papillomavirus DNA in Genital Scrapes”, J. Clin. Microbiol., 1990, pp. 2076-2081, vol. 28, No. 9, American Society for Microbiology, Washington, D.C., USA.
Schneider-Gadicke et al., “Different Human Cervical Carcinoma Cell Lines Show Similiar Transcription Patterns of Human Papillomavirus Type 18 Early Genes”, The EMBO Journal, 1986, pp. 2285-2292, vol. 5, No. 9, IRL Press Limited, Oxford, England.
Shirasawa et al., “Transcriptional Differences of the Human Papillomavirus Type 16 Genome between Precancerous Lesions and Invasive Carcinomas”, J. Virol., 1988, pp. 1022-1027, vol. 62, No. 3, American Society for Microbiology, Washington, D.C., USA.
Smotkin et al., “Oncogenic and Nononcogenic Human Genital Papillomaviruses Generate the E7 mRNA by Different Mechanisms”, J. Virol., 1989, pp. 1441-1447, vol. 63, No. 3, American Society for Microbiology, Washington, D.C., USA.
Snijders et al., “Human Papillomavirus Type 33 in a Tonsillar Carcinoma Generates Its Putative E7 mRNA via Two E6* Transcript Species Which Are Terminated at Different Early Region Poly(A) Sites”, J. Virol., 1992, pp. 3172-3178, vol. 66, No. 5, American Society for Microbiology, Washington, D.C., USA.
Yasumoto et al., “Differential Early Viral Gene Expression in Two Stages of Human Papillomavirus Type 16 DNA-Induced Malignant Transformation”, J. Virol., 1987, pp. 2165-2172, vol. 7, No. 6, American Society for Microbiology, Washington, D.C., USA.
Van Den Brule et al., “Nonradioactive RNA in Situ Hybridization Detection of Human Papillomavirus 16-E7 Transcripts in Squamous Cell Carcinomas of the Uterine Cervix Using Confocal Laser Scan Microscopy,” Am. J. Pathol., 1991, pp. 1037-1045, vol. 139, No. 5, American Society for Investigative Pathology, Bethesda, MD, USA.
Brentano Steven T.
Carter Nick M.
Gordon Patricia
Hammond Philip W.
Gen-Probe Incorporated
Gen-Probe Patent Dept.
Gritzmacher Christine A.
Kim Young J
LandOfFree
Oligonucleotides for detecting human papilloma virus in a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotides for detecting human papilloma virus in a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides for detecting human papilloma virus in a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2655955